
Novo Nordisk Sues Eli Lilly Over Allegedly Misleading Drug Ads
Novo Nordisk has filed a lawsuit against Eli Lilly in a U.S. court, alleging that Lilly's advertising campaigns for its obesity and diabetes drugs, Zepbound and Mounjaro, mislead consumers by using outdated clinical trials to compare efficacy against Novo's rival injections, Wegovy and Ozempic.







